DocuSign (DOCU) Unveils New AI Tools, Is The Discount Enough?

DocuSign (DOCU) is back in focus after unveiling new AI powered agreement tools at its Momentum London conference, including the Iris AI engine and customizable agents designed to speed contract workflows for large customers.

See our latest analysis for DocuSign.

Recent AI announcements and index inclusions appear to have lifted sentiment in the very short term, with a 1 day share price return of 2.47% and 7 day share price return of 4.13%. However, the year to date share price return is down 27.68% and the 1 year total shareholder return is down 39.59%, pointing to weak longer term momentum despite the latest product and index news.

If DocuSign's AI push has caught your attention, it could be a good moment to see what else is happening across smaller AI names using the 62 profitable AI stocks that aren't just burning cash

DocuSign now trades at a sizeable discount to both analyst targets and some intrinsic value estimates, even after the AI driven bounce. Is that a genuine mispricing, or is the market applying reasonable caution to this story?

Most Popular Narrative: 22% Undervalued

On the most followed narrative, DocuSign's fair value of $60.16 sits meaningfully above the last close at $46.90, putting the focus squarely on what is baked into those assumptions.

Sustained adoption of digital workflows across global industries and increased prevalence of remote/hybrid work environments is driving persistent demand for eSignature, contract lifecycle management (CLM), and AI-powered agreement management (IAM) solutions. This is reflected in accelerating direct sales, healthy new bookings, and improving renewal rates, providing strong ongoing support for revenue and billings growth.

Read the complete narrative.

Curious what is behind that value gap for DocuSign? The narrative leans on steady revenue compounding, firmer margins, and a future earnings multiple more often associated with higher growth software leaders.

Result: Fair Value of $60.16 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the DocuSign narrative could be challenged if growth in the core eSignature business slows further, or if rising competition erodes pricing power and margins.

Find out about the key risks to this DocuSign narrative.

Next Steps

Given the mixed sentiment around DocuSign's valuation and growth story, it may be useful to review the underlying data for yourself, including the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond DocuSign?

If DocuSign has sharpened your focus on where capital goes next, do not stop there. Broaden your watchlist with a few targeted idea lists built from hard numbers.

• Spot potential bargains early by scanning companies that look mispriced on fundamentals using the 41 high quality undervalued stocks.
• Strengthen your income stream by reviewing stocks offering higher yields and resilient payouts with the 8 dividend fortresses.
• Dial down portfolio risk by focusing on companies screened for robust balance sheets and solid underlying metrics through the solid balance sheet and fundamentals stocks screener (47 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com